HEADER TRANSCRIPTION 08-JUN-22 8D8I TITLE CRYSTAL STRUCTURE OF REVERB ALPHA IN COMPLEX WITH SYNTHETIC AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP D MEMBER 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: REV-ERBA-ALPHA,V-ERBA-RELATED PROTEIN 1,EAR-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COREPRESSOR 1; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: N-COR,N-COR1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1D1, EAR1, HREV, THRAL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: NCOR1, KIAA1047; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS REV-ERB, NUCLEAR RECEPTOR, AGONIST, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR C.RONIN,F.CIESIELSKI,L.HEGAZY,P.T.BURRIS REVDAT 2 03-APR-24 8D8I 1 REMARK REVDAT 1 14-DEC-22 8D8I 0 JRNL AUTH M.H.MURRAY,A.C.VALFORT,T.KOELBLEN,C.RONIN,F.CIESIELSKI, JRNL AUTH 2 A.CHATTERJEE,G.B.VEERAKANELLORE,B.ELGENDY,J.K.WALKER, JRNL AUTH 3 L.HEGAZY,T.P.BURRIS JRNL TITL STRUCTURAL BASIS OF SYNTHETIC AGONIST ACTIVATION OF THE JRNL TITL 2 NUCLEAR RECEPTOR REV-ERB. JRNL REF NAT COMMUN V. 13 7131 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36414641 JRNL DOI 10.1038/S41467-022-34892-4 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 75.8 REMARK 3 NUMBER OF REFLECTIONS : 7248 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 363 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.74 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 17.95 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2832 REMARK 3 BIN FREE R VALUE : 0.2015 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 18 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1761 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.73490 REMARK 3 B22 (A**2) : 0.73490 REMARK 3 B33 (A**2) : -1.46970 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.380 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 3.057 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.321 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1824 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2469 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 648 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 341 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1813 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 240 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1471 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.46 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.42 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8D8I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000263922. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : STARANISO 2.3.77 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7248 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.504 REMARK 200 RESOLUTION RANGE LOW (A) : 73.027 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.5 REMARK 200 DATA REDUNDANCY : 8.110 REMARK 200 R MERGE (I) : 0.06910 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.4400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 7.46 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 73.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.97 REMARK 200 R MERGE FOR SHELL (I) : 0.02850 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 51.19 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: IN HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 80MM NA HEPES PH7.5, 200MM PROLINE, 8% REMARK 280 GLYCEROL AND 18% PEG3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 295.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 7555 X+2/3,Y+1/3,Z+1/3 REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3 REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3 REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3 REMARK 290 13555 X+1/3,Y+2/3,Z+2/3 REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3 REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3 REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 57.53650 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 33.21871 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 35.77333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 57.53650 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 33.21871 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 35.77333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 57.53650 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 33.21871 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 35.77333 REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 57.53650 REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 33.21871 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 35.77333 REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 57.53650 REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 33.21871 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 35.77333 REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 57.53650 REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 33.21871 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 35.77333 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 66.43743 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 71.54667 REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 66.43743 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 71.54667 REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 66.43743 REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 71.54667 REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 66.43743 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 71.54667 REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 66.43743 REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 71.54667 REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 66.43743 REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 71.54667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 277 REMARK 465 SER A 278 REMARK 465 HIS A 279 REMARK 465 MET A 280 REMARK 465 PRO A 281 REMARK 465 GLU A 282 REMARK 465 TYR A 403 REMARK 465 ALA A 404 REMARK 465 HIS A 405 REMARK 465 ASP A 406 REMARK 465 LYS A 407 REMARK 465 LEU A 408 REMARK 465 GLY A 409 REMARK 465 SER A 410 REMARK 465 SER A 411 REMARK 465 PRO A 412 REMARK 465 GLY A 413 REMARK 465 ASN A 414 REMARK 465 PHE A 415 REMARK 465 ASN A 416 REMARK 465 ALA A 417 REMARK 465 ASN A 418 REMARK 465 HIS A 419 REMARK 465 ALA A 420 REMARK 465 SER A 421 REMARK 465 GLY A 422 REMARK 465 SER A 423 REMARK 465 PRO A 424 REMARK 465 HIS A 425 REMARK 465 GLY A 426 REMARK 465 ARG A 427 REMARK 465 SER A 428 REMARK 465 GLY A 429 REMARK 465 ASP A 612 REMARK 465 ALA A 613 REMARK 465 GLN A 614 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 300 -72.61 -85.20 REMARK 500 PRO A 458 107.29 -52.42 REMARK 500 LEU A 498 -6.43 -59.98 REMARK 500 MET A 513 -101.48 9.84 REMARK 500 PHE B2063 34.77 -95.19 REMARK 500 REMARK 500 REMARK: NULL DBREF 8D8I A 281 424 UNP P20393 NR1D1_HUMAN 281 323 DBREF 8D8I A 425 614 UNP P20393 NR1D1_HUMAN 425 614 DBREF 8D8I B 2045 2064 UNP O75376 NCOR1_HUMAN 2045 2064 SEQADV 8D8I GLY A 277 UNP P20393 EXPRESSION TAG SEQADV 8D8I SER A 278 UNP P20393 EXPRESSION TAG SEQADV 8D8I HIS A 279 UNP P20393 EXPRESSION TAG SEQADV 8D8I MET A 280 UNP P20393 EXPRESSION TAG SEQADV 8D8I ALA B 2056 UNP O75376 CYS 2056 ENGINEERED MUTATION SEQRES 1 A 237 GLY SER HIS MET PRO GLU PRO THR VAL GLU ASP VAL ILE SEQRES 2 A 237 SER GLN VAL ALA ARG ALA HIS ARG GLU ILE PHE THR TYR SEQRES 3 A 237 ALA HIS ASP LYS LEU GLY SER SER PRO GLY ASN PHE ASN SEQRES 4 A 237 ALA ASN HIS ALA SER GLY SER PRO HIS GLY ARG SER GLY SEQRES 5 A 237 ARG THR VAL GLN GLU ILE TRP GLU ASP PHE SER MET SER SEQRES 6 A 237 PHE THR PRO ALA VAL ARG GLU VAL VAL GLU PHE ALA LYS SEQRES 7 A 237 HIS ILE PRO GLY PHE ARG ASP LEU SER GLN HIS ASP GLN SEQRES 8 A 237 VAL THR LEU LEU LYS ALA GLY THR PHE GLU VAL LEU MET SEQRES 9 A 237 VAL ARG PHE ALA SER LEU PHE ASN VAL LYS ASP GLN THR SEQRES 10 A 237 VAL MET PHE LEU SER ARG THR THR TYR SER LEU GLN GLU SEQRES 11 A 237 LEU GLY ALA MET GLY MET GLY ASP LEU LEU SER ALA MET SEQRES 12 A 237 PHE ASP PHE SER GLU LYS LEU ASN SER LEU ALA LEU THR SEQRES 13 A 237 GLU GLU GLU LEU GLY LEU PHE THR ALA VAL VAL LEU VAL SEQRES 14 A 237 SER ALA ASP ARG SER GLY MET GLU ASN SER ALA SER VAL SEQRES 15 A 237 GLU GLN LEU GLN GLU THR LEU LEU ARG ALA LEU ARG ALA SEQRES 16 A 237 LEU VAL LEU LYS ASN ARG PRO LEU GLU THR SER ARG PHE SEQRES 17 A 237 THR LYS LEU LEU LEU LYS LEU PRO ASP LEU ARG THR LEU SEQRES 18 A 237 ASN ASN MET HIS SER GLU LYS LEU LEU SER PHE ARG VAL SEQRES 19 A 237 ASP ALA GLN SEQRES 1 B 20 THR HIS ARG LEU ILE THR LEU ALA ASP HIS ILE ALA GLN SEQRES 2 B 20 ILE ILE THR GLN ASP PHE ALA HET QFX A4000 34 HETNAM QFX (4S)-6-[([1,1'-BIPHENYL]-2-YL)OXY]-3-CHLORO[1,2, HETNAM 2 QFX 4]TRIAZOLO[4,3-B]PYRIDAZINE FORMUL 3 QFX C17 H11 CL N4 O FORMUL 4 HOH *26(H2 O) HELIX 1 AA1 THR A 284 PHE A 300 1 17 HELIX 2 AA2 THR A 431 HIS A 456 1 26 HELIX 3 AA3 SER A 464 ALA A 485 1 22 HELIX 4 AA4 GLN A 506 MET A 511 5 6 HELIX 5 AA5 GLY A 514 SER A 529 1 16 HELIX 6 AA6 THR A 533 SER A 547 1 15 HELIX 7 AA7 ASN A 555 ARG A 578 1 24 HELIX 8 AA8 SER A 583 LEU A 590 1 8 HELIX 9 AA9 LEU A 590 SER A 603 1 14 HELIX 10 AB1 LEU B 2051 PHE B 2063 1 13 SHEET 1 AA1 3 PHE A 488 ASN A 489 0 SHEET 2 AA1 3 THR A 494 MET A 496 -1 O THR A 494 N ASN A 489 SHEET 3 AA1 3 THR A 502 SER A 504 -1 O TYR A 503 N VAL A 495 SHEET 1 AA2 2 LEU A 606 ARG A 610 0 SHEET 2 AA2 2 HIS B2046 THR B2050 -1 O ARG B2047 N PHE A 609 CRYST1 115.073 115.073 107.320 90.00 90.00 120.00 H 3 2 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008690 0.005017 0.000000 0.00000 SCALE2 0.000000 0.010035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009318 0.00000